21168618

Source:http://linkedlifedata.com/resource/pubmed/id/21168618

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022671, umls-concept:C0024501, umls-concept:C0038317, umls-concept:C0376387
pubmed:issue	10
pubmed:dateCreated	2010-12-20
pubmed:abstractText	We investigated the efficacy and safety of an immunosuppressive regimen consisting of tacrolimus or cyclosporine, with basiliximab, mycophenolate mofetil or mizoribine, and low-dose steroids (prednisone <2.5 mg/d) for kidney transplant recipients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0243532
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribonucleosides, http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus, http://linkedlifedata.com/resource/pubmed/chemical/basiliximab, http://linkedlifedata.com/resource/pubmed/chemical/bredinin, http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1873-2623
pubmed:author	pubmed-author:FujisawaMM, pubmed-author:HiraiTT, pubmed-author:IchikawaYY, pubmed-author:KishikawaHH, pubmed-author:KokadoYY, pubmed-author:KyoMM, pubmed-author:NishimuraKK, pubmed-author:SodaTT, pubmed-author:TakedaMM, pubmed-author:YamanakaKK
pubmed:copyrightInfo	Copyright © 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	42
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4030-2
pubmed:meshHeading	pubmed-meshheading:21168618-Adult, pubmed-meshheading:21168618-Aged, pubmed-meshheading:21168618-Antibodies, Monoclonal, pubmed-meshheading:21168618-Creatinine, pubmed-meshheading:21168618-Cyclosporine, pubmed-meshheading:21168618-Dose-Response Relationship, Drug, pubmed-meshheading:21168618-Drug Therapy, Combination, pubmed-meshheading:21168618-Female, pubmed-meshheading:21168618-Graft Rejection, pubmed-meshheading:21168618-Graft Survival, pubmed-meshheading:21168618-Humans, pubmed-meshheading:21168618-Immunosuppressive Agents, pubmed-meshheading:21168618-Kidney Transplantation, pubmed-meshheading:21168618-Male, pubmed-meshheading:21168618-Middle Aged, pubmed-meshheading:21168618-Mycophenolic Acid, pubmed-meshheading:21168618-Prednisone, pubmed-meshheading:21168618-Recombinant Fusion Proteins, pubmed-meshheading:21168618-Ribonucleosides, pubmed-meshheading:21168618-Tacrolimus
pubmed:year	2010
pubmed:articleTitle	Low-dose steroid maintenance for renal transplant recipients.
pubmed:affiliation	Renal Transplantation Center, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan. hidefumi69@hotmail.com
pubmed:publicationType	Journal Article